RVL Pharmaceuticals plc – NASDAQ:RVLP
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 7 hours
RVL Pharmaceuticals stock price monthly change
-76.07%
month
RVL Pharmaceuticals stock price quarterly change
-96.46%
quarter
RVL Pharmaceuticals stock price yearly change
-98.37%
year
RVL Pharmaceuticals key metrics
Market Cap | 3.14M |
Enterprise value | 116.21M |
P/E | -1.92 |
EV/Sales | 1.45 |
EV/EBITDA | -1.79 |
Price/Sales | 1.29 |
Price/Book | 2.02 |
PEG ratio | -0.04 |
EPS | -0.70 |
Revenue | 36.91M |
EBITDA | -36.33M |
Income | -68.26M |
Revenue Q/Q | -2.24% |
Revenue Y/Y | 5.63% |
Profit margin | -88.7% |
Oper. margin | -34.92% |
Gross margin | 82.63% |
EBIT margin | -34.92% |
EBITDA margin | -98.42% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeRVL Pharmaceuticals stock price history
RVL Pharmaceuticals stock forecast
RVL Pharmaceuticals financial statements
| Sep 2022 | 10.02M | -14.44M | -144.14% |
|---|---|---|---|
| Dec 2022 | 9.80M | -18.31M | -186.8% |
| Mar 2023 | 8.83M | -11.61M | -131.48% |
| Jun 2023 | 8.25M | -23.88M | -289.28% |
| Sep 2022 | 155355000 | 86.80M | 55.88% |
|---|---|---|---|
| Dec 2022 | 128510000 | 77.41M | 60.24% |
| Mar 2023 | 111108000 | 71.10M | 64% |
| Jun 2023 | 85404000 | 69.07M | 80.88% |
| Sep 2022 | -10.09M | 231K | 42.20M |
|---|---|---|---|
| Dec 2022 | -16.43M | -172K | 1.39M |
| Mar 2023 | -5.81M | -1.22M | -4.86M |
| Jun 2023 | -12.06M | -959K | -460K |
RVL Pharmaceuticals alternative data
| Aug 2023 | 125 |
|---|---|
| Sep 2023 | 125 |
| Oct 2023 | 125 |
| Nov 2023 | 125 |
| Dec 2023 | 125 |
| Jan 2024 | 125 |
| Feb 2024 | 125 |
| Mar 2024 | 125 |
| Apr 2024 | 125 |
| May 2024 | 125 |
| Jun 2024 | 125 |
| Jul 2024 | 125 |
RVL Pharmaceuticals other data
6.79%
-20.60%
of RVLP is owned by hedge funds
23
-13
6.09M
-19.30M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Oct 2023 | 0 | 25724632 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | ALTCHEM LTD 10 percent owner | Ordinary Shares | 4,758,899 | $0.03 | $147,526 | ||
Sale | HARSAUL FOUNDATION 10 percent owner | Ordinary Shares | 4,758,899 | $0.03 | $147,526 | ||
Sale | ALTCHEM LTD 10 percent owner | Ordinary Shares | 9,363,760 | $0.05 | $430,733 | ||
Sale | HARSAUL FOUNDATION 10 percent owner | Ordinary Shares | 3,421,537 | $0.07 | $222,400 | ||
Sale | ALTCHEM LTD 10 percent owner | Ordinary Shares | 3,421,537 | $0.07 | $222,400 | ||
Purchase | AVISTA HEALTHCARE PARTNERS, L.P. 10 percent owner | Ordinary Shares | 8,000,000 | $1.55 | $12,400,000 | ||
Purchase | VENKATARAMAN SRIRAM director, 10 percent owner | Ordinary Shares | 8,000,000 | $1.55 | $12,400,000 | ||
Purchase | BURGSTAHLER DAVID F director, 10 percent owner | Ordinary Shares | 8,000,000 | $1.55 | $12,400,000 | ||
Purchase | MARKISON BRIAN A director, officer.. | Ordinary Shares | 850,000 | $1.55 | $1,317,500 | ||
Purchase | SCHAUB JAMES officer: EVP and .. | Ordinary Shares | 150,000 | $1.55 | $232,500 |
| Quarter | Transcript |
|---|---|
| Q2 2023 14 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Q1 2023 11 May 2023 | Q1 2023 Earnings Call Transcript |
| Q4 2022 20 Mar 2023 | Q4 2022 Earnings Call Transcript |
| Q3 2022 10 Nov 2022 | Q3 2022 Earnings Call Transcript |
-
When is RVL Pharmaceuticals's next earnings date?
Unfortunately, RVL Pharmaceuticals's (RVLP) next earnings date is currently unknown.
-
Does RVL Pharmaceuticals pay dividends?
No, RVL Pharmaceuticals does not pay dividends.
-
How much money does RVL Pharmaceuticals make?
RVL Pharmaceuticals has a market capitalization of 3.14M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 184.1% to 49.72M US dollars.
-
What is RVL Pharmaceuticals's stock symbol?
RVL Pharmaceuticals plc is traded on the NASDAQ under the ticker symbol "RVLP".
-
What is RVL Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of RVL Pharmaceuticals?
Shares of RVL Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does RVL Pharmaceuticals have?
As Jul 2024, RVL Pharmaceuticals employs 125 workers.
-
When RVL Pharmaceuticals went public?
RVL Pharmaceuticals plc is publicly traded company for more then 6 years since IPO on 19 Oct 2018.
-
What is RVL Pharmaceuticals's official website?
The official website for RVL Pharmaceuticals is rvlpharma.com.
-
Where are RVL Pharmaceuticals's headquarters?
RVL Pharmaceuticals is headquartered at 400 Crossing Boulevard, Bridgewater, NJ.
-
How can i contact RVL Pharmaceuticals?
RVL Pharmaceuticals's mailing address is 400 Crossing Boulevard, Bridgewater, NJ and company can be reached via phone at +90 88091300.
RVL Pharmaceuticals company profile:
RVL Pharmaceuticals plc
rvlpharma.comExchange:
NASDAQ
Full time employees:
125
Industry:
Biotechnology
Sector:
Healthcare
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
400 Crossing Boulevard
Bridgewater, NJ 08807
Bridgewater, NJ 08807
CIK: 0001739426
ISIN: IE00BF2HDL56
CUSIP: G6S41R101
